3.0 T cardiovascular magnetic resonance in patients treated with coronary stenting for myocardial infarction: Evaluation of short term safety and image quality

International Journal of Cardiovascular Imaging

Volumn 24, Issue 3, 2008, Pages 283-291

  Nijveldt, Robin ^a,b   Hirsch, Alexander ^b,c   Hofman, Mark B M ^a   Beek, Aernout M ^a   Spijkerboer, Anje M ^c   Piek, Jan J ^c   van Rossum, Albert C ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

3.0 T; Acute myocardial infarction; Cardiovascular magnetic resonance; Late gadolinium enhancement; Safety

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; GADOTERATE MEGLUMINE; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; CATHETERIZATION; CINERADIOGRAPHY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY STENT; FEMALE; HEART INFARCTION; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; POSTOPERATIVE PERIOD; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REPEAT PROCEDURE; ARTIFACT; COMPARATIVE STUDY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; STENT; TREATMENT OUTCOME;

ARTIFACTS; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MEGLUMINE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS; STATISTICS, NONPARAMETRIC; STENTS; TREATMENT OUTCOME;

EID: 45149088063     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-007-9264-2     Document Type: Article

References (28)

1. Pennell DJ, Sechtem UP, Higgins CB et al (2004) Clinical indications for cardiovascular magnetic resonance (CMR): Consensus panel report. Eur Heart J 25(21):1940-1965
2. Schietinger BJ, Voros S, Isbell DC et al (2007) Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure? Int J Cardiovasc Imaging, doi: 10.1007/s10554-006-9200-x
3. Wu KC, Zerhouni EA, Judd RM et al (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97(8):765-772
4. Kim RJ, Wu E, Rafael A et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343(20):1445-1453
5. Beek AM, Kuhl HP, Bondarenko O et al (2003) Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 42(5):895-901
6. Hinton DP, Wald LL, Pitts J et al (2003) Comparison of cardiac MRI on 1.5 and 3.0 Tesla clinical whole body systems. Invest Radiol 38(7):436-442
7. Schar M, Kozerke S, Fischer SE et al (2004) Cardiac SSFP imaging at 3 Tesla. Magn Reson Med 51(4):799-806
8. Gutberlet M, Schwinge K, Freyhardt P et al (2005) Influence of high magnetic field strengths and parallel acquisition strategies on image quality in cardiac 2D CINE magnetic resonance imaging: Comparison of 1.5 T vs. 3.0 T. Eur Radiol 15(8):1586-1597
9. Michaely HJ, Nael K, Schoenberg SO et al (2006) Analysis of cardiac function-comparison between 1.5 Tesla and 3.0 Tesla cardiac cine magnetic resonance imaging: Preliminary experience. Invest Radiol 41(2):133-140
10. Gutberlet M, Noeske R, Schwinge K et al (2006) Comprehensive cardiac magnetic resonance imaging at 3.0 Tesla: Feasibility and implications for clinical applications. Invest Radiol 41(2):154-167
11. Alpert JS, Thygesen K, Antman E et al (2000) Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36(3):959-969
12. Ryan TJ, Antman EM, Brooks NH et al (1999) 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary andArecommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 100(9):1016-1030
13. Markl M, Pelc NJ (2004) On flow effects in balanced steady-state free precession imaging: Pictorial description, parameter dependence, and clinical implications. J Magn Reson Imaging 20(4):697-705
14. New PF, Rosen BR, Brady TJ et al (1983) Potential hazards and artifacts of ferromagnetic and nonferromagnetic surgical and dental materials and devices in nuclear magnetic resonance imaging. Radiology 147(1):139-148
15. Shellock FG, Crues JV (1988) High-field-strength MR imaging and metallic biomedical implants: An ex vivo evaluation of deflection forces. Am J Roentgenol 151(2):389-392
16. ASTM International: F2182 (2003) Test method for measurement of radio frequency induced heating near passive implants during magnetic resonance imaging. American Society for Testing and Materials (ASTM) International, West Conshohocken, PA
17. Hug J, Nagel E, Bornstedt A et al (2000) Coronary arterial stents: safety and artifacts during MR imaging. Radiology 216(3):781-787
18. Shellock FG, Forder JR (2005) Drug eluting coronary stent: In vitro evaluation of magnet resonance safety at 3 Tesla. J Cardiovasc Magn Reson 7(2):415-419
19. Gerber TC, Fasseas P, Lennon RJ et al (2003) Clinical safety of magnetic resonance imaging early after coronary artery stent placement. J Am Coll Cardiol 42(7):1295-1298
20. Schroeder AP, Houlind K, Pedersen EM et al (2000) Magnetic resonance imaging seems safe in patients with intracoronary stents. J Cardiovasc Magn Reson 2(1):43-49
21. Syed MA, Carlson K, Murphy M et al (2006) Long-term safety of cardiac magnetic resonance imaging performed in the first few days after bare-metal stent implantation. J Magn Reson Imaging 24(5):1056-1061
22. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 361(9351):13-20
23. Barkhausen J, Ruehm SG, Goyen M et al (2001) MR evaluation of ventricular function: True fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: Feasibility study. Radiology 219(1):264-269
24. Constantinides CD, Atalar E, McVeigh ER (1997) Signal-to-noise measurements in magnitude images from NMR phased arrays. Magn Reson Med 38(5):852-857
25. Price RR, Axel L, Morgan T et al (1990) Quality assurance methods and phantoms for magnetic resonance imaging: Report of AAPM nuclear magnetic resonance Task Group No. 1. Med Phys 17(2):287-295
26. Petersen SE, Mohrs OK, Horstick G et al (2004) Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging. J Cardiovasc Magn Reson 6(2):541-548
27. Wagner A, Mahrholdt H, Thomson L et al (2006) Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. J Am Coll Cardiol 47(10):2027-2033
28. Sharma P, Socolow J, Patel S et al (2006) Effect of Gd-DTPA-BMA on blood and myocardial T1 at 1.5T and 3T in humans. J Magn Reson Imaging 23(3):323-330